Industry News
Related Searches:
Filter by:
1426 - 1440 of 2424 results
April 29, 2009
ICON has acquired a 33,000-sq.-ft. Phase I facility in Omaha, NE from the former Qualia Clinical Services, Inc., with a capacity of as many as 100 beds.
Read More »
April 27, 2009
Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility.
Read More »
April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.
Read More »
April 21, 2009
Chiltern International Ltd. will acquire Vigiun, a full service CRO located in Sao Paulo, Brazil. Vigiun, established in 1999 by Eduardo Forleo, M.D., and Elisa Halker, BSN, has experience conducting clinical trials in a variety of therapeutic areas, incl
Read More »
April 20, 2009
GlaxoSmithKline and Stiefel Laboratories, Inc. have signed an agreement to create a new specialist dermatology business. Under the terms of the agreement, GSK will acquire Stiefel for $2.9 billion in cash with a potential further $0.3 billion cash payment
Read More »
April 20, 2009
AMRI has completed the relocation of its Bothell, WA research unit into approximately 44,000 sq.-ft. of nearby newly refurbished lab and office space.
Read More »
April 17, 2009
Patheon is expanding its Toronto manufacturing facility, adding 10,000 sq. ft. of GMP space dedicated to the production of oral contraceptives.
Read More »
April 16, 2009
GlaxoSmithKline and Pfizer have entered into an agreement to create a new company focused solely on research, development and commercialization of HIV drugs.
Read More »
April 16, 2009
The Chemical Biological Medical Systems Project Management Office of the U.S. Department of Defense (DoD) has signed a four-year agreement with Cangene Corp. to purchase its Vaccinia Immune Globulin Intravenous (Human) (VIG) for use by U.S. military perso
Read More »
April 15, 2009
Sanofi-aventis has entered an agreement to acquire BiPar Sciences, Inc., a privately held U.S. biopharmaceutical company developing tumor-selective approaches for the treatment of cancer, for as much as $500 million.
Read More »
April 14, 2009
Oxygen Biotherapeutics, Inc. has reached a development and commercial supply agreement with Hospira's One 2 One Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte, a perfluorocarbon (PFC) therapeutic oxygen carrier.
Read More »
April 13, 2009
PharmEng International Inc. has decided to reduce corporate costs as part of its ongoing restructuring efforts.
Read More »
April 9, 2009
Genentech will voluntary withdraw the psoriasis drug Raptiva (efalizumab) from the U.S. market due to the association with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal CNS disease.
Read More »
April 9, 2009
Following a GMP inspection of Confab Laboratories’ facilities, systems, and procedures, the FDA has classified the facility as acceptable. No objectionable items where issued.
Read More »
April 9, 2009
DSM has entered into a multi-million dollar contract with Shire US Manufacturing, Inc. under which DSM will manufacture and supply specialty pharmaceutical products for Shire.
Read More »
1426 - 1440 of 2424 results
